“…In these studies, micellar carriers have been developed for the treatment of psoriasis (tacrolimus and cyclosporine) [64,65]; and photo-aging (all-trans retinoic acid) [66]; breast cancer (endoxifen) [67]; and skin cancer (oridonin) [68], fungal infections (clotrimazole, econazole nitrate and fluconazole) [21], and acne (benzoyl peroxide) [69], and the skin permeation of drugs from micelles was also examined. The micellar carriers of quercetin and rutin as antioxidant compounds [70], and polymeric micelle loaded sumatriptan for the treatment of pain in migraine [71] have also been optimised, and the efficacy of these formulations have been evaluated with in vitro/in vivo studies. In another study, an anti-inflammatory drug was loaded into a core of polymeric micelles, which resulted in delayed drug release and slow drug permeation due to the core and shell structure.…”